Diabetes management programs can be delivered digitally or in a traditional in-person setting, but there are benefits and drawbacks to each, explained Neal Kaufman, MD, founder and chief medical officer of Canary Health.
Diabetes management programs can be delivered digitally or in a traditional in-person setting, but there are benefits and drawbacks to each, explained Neal Kaufman, MD, founder and chief medical officer of Canary Health.
Transcript (slightly modified)
What are the advantages of digital delivery of a chronic disease management program, compared with an in-person program?
I think they’re both very important. They’re both excellent ways of bringing research-proven approaches to help people self-manage their conditions. Digital has certain advantages over in-person, and in-person has advantages over digital.
Digital is ubiquitous, 24/7, the person doesn’t need to get in their car to get to the appointment, they can access it from the privacy of their home, they can come on for 5 or 10 minutes if that’s all they have that day, or they can spend an hour or longer if need be. It identifies and helps people who don’t like to join groups. Many people are not happy with that approach; they want to be anonymous in their conversations.
In-person is in-person, and it allows you to have a more intimate relationship with individuals who come to your group. It has benefits where individuals are able to share and have that direct social support. Digital provides indirect social support, and depending on the individual, some approaches work better than others.
In-person has a challenge, in that you have to get people to show up at the same time, at the same place, an hour a week or more depending on the program, and that can have some significant logistics challenges.
So, I actually believe that the future will have combined approaches where individuals will be given the choice between a digital delivery of that program, in this case a diabetes prevention program or a chronic disease self-management program, and also in-person delivery of those same programs.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More